Preview

Medical alphabet

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Scabies in a comorbid patient with severe neurological pathology: a clinical case

https://doi.org/10.33667/2078-5631-2024-31-46-51

Abstract

The late diagnosis of scabies in severe neurological patients may be related to the peculiarities of their general condition and lifestyle. Comorbid patients take a large number of medications for a long time, including hormonal ones, which can mask the classic manifestations of scabies. Due to the probability of the absence of characteristic complaints in patients with severe neurological pathology, we present the following clinical case. We observed patient N., who was in the department of anesthesiology-intensive care with intensive care and intensive care wards at the Federal State Budgetary Institution «FCMN» of the FMBA of Russia. Diagnosis upon admission: repeated multifocal cerebral infarction in the vertebrobasillary basin with the presence of foci of infarction in the acute/superacute stage in the basins of the main artery, right middle cerebral artery, right anterior choroidal artery, left middle cerebral artery, left superior cerebellar artery from 08/09/2024, 08/12/2024. An unspecified pathogenetic variant of TOAST. The modified Rankin scale is initially 5 points. At the time of hospitalization, 5 points (ICD 10 I63.5). Upon admission, the patient was found to have a rash, and therefore he was immediately consulted by a dermatovenerologist. Based on a set of clinical data and laboratory detection of the pathogen, patient N. was diagnosed with B 86 – scabies. At the prehospital stage, scabies was not diagnosed in a timely manner. Late diagnosis of scabies leads to the spread of the disease and the maintenance of an unfavorable epidemiological situation.

About the Authors

T. A. Gaydina
N.I. Pirogov Russian National Research Medical University; Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency
Russian Federation

Gaydina Tatiana A., PhD Med, associate professor at Dept of Dermatovenereology named after academician Yu. K. Skripkin; physician

Moscow



O. Yu. Milushkina
N.I. Pirogov Russian National Research Medical University
Russian Federation

Milushkina Olga Yu., DM Sci (habil.), professor, corresponding member of the Russian Academy of Sciences, vice-rector for Academic Affairs, director of the Z. P. Solovyov Institute of Preventive Medicine, head of Dept of Hygiene of the Z. P. Solovyov Institute of Preventive Medicine

Moscow



N. A. Skoblina
N.I. Pirogov Russian National Research Medical University
Russian Federation

Skoblina Natalya A., DM Sci (habil.), professor at Dept of Hygiene of the Z. P. Solovyov Institute of Preventive Medicine

Moscow



R. T. Tairova
N.I. Pirogov Russian National Research Medical University; Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency
Russian Federation

Tairova Raisa T., PhD Med, associate professor at Dept of Neurology, Neurosurgery and Medical Genetics; chief physician

Moscow



References

1. World Health Organization. Scabies. Fact sheets. [Electronic resource]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/scabies (date of the application: 09.09.2024). (In Russ.).

2. Clinical recommendations «Scabies», All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists», 2016. (In Russ.).

3. Federal State Budgetary Institution «Central Research Institute of Organization and Informatization of Healthcare» Ministry of Health of the Russian Federation. Resources and activities of medical organizations of dermatovenerological profile. The incidence of sexually transmitted infections, infectious skin diseases and skin diseases for 2017–2018. Statistical materials. [Electronic resource]. URL: https://mednet.ru. (date of the application: 09.09.2024) (In Russ.).

4. Sokolova T. V., Maliarchuk A. P. Cyclicity of increasing and decreasing incidence rates of scabies in 1968–2011. Russian Journal of Clinical Dermatology and Venereology. 2014;12(3):87–95. (In Russ.).

5. Tlish M. M., Kuznetsova T. G., Naatyzh Zh. Yu., Erokhina E. V. Social-epidemiological pattern of scabies in gerontological patients. Russian Medical Journal. 2022;3:55–58. (In Russ.).

6. Gaydina T. A., Dvornikov A. S., Milushkina O. Yu., Gamidova A. A. Diagnosis and Prevention of Scabies in Low Mobility Patients with Cognitive Impairment. The Russian Archives of Internal Medicine. 2023;13(3):232–240. doi:10.20514/2226-6704-2023-13-3-232-240. (In Russ.).

7. Ivanova M. A. The incidence of scabies in various age groups of the population of the Russian Federation in 2010–2014. Klinicheskaya Dermatologiya i Venerologiya. 2016;15(4):4–8. doi: 10.17116/klinderma20161544–8. (In Russ.).

8. Sokolova T. V., Gladko V. V., Malyarchuk A. P., et al. Scabies: the seamy side of official statistics. Meditsinskiy vestnik MVD. 2020;4(107):68–76. (In Russ.).

9. Kolomiets V. M., Polshikova N. A., Petrov A. Yu., et al. Epidemic situation and features of accompanying therapy in the treatment of socially significant infectious diseases in penitentiary populations before, during, and after the COVID-19 pandemic. Antibiotics and Chemotherapy. 2024;69(1–2):44–50. doi: 10.37489/0235-2990-2024-69-1-2-44-50. (In Russ.).

10. Shchava S. N., Rusinov V. I., Meshcheryakova K. E., Popov V. V. Modern features of the course of scabies in elderly people. Lechebnoe delo. 2021;(1):117–120. doi: 10.24412/2071-5315-2021-12297. (In Russ.).

11. Thomas C., Coates S. J., Engelman D., et al. Ectoparasites: Scabies. J Am Acad Dermatol. 2020;82(3):533–548. doi: 10.1016/j.jaad.2019.05.109.

12. Arora P., Rudnicka L., Sar-Pomian M., et al. Scabies: A comprehensive review and current perspectives. Dermatol Ther. 2020;33(4): e13746. doi: 10.1111/dth.13746.

13. Bergamin G., Hudson J., Currie B. J., Mounsey K. E. A systematic review of immunosuppressive risk factors and comorbidities associated with the development of crusted scabies. International Journal of Infectious Diseases. 2024;143:107036. doi: 10.1016/j.ijid.2024.107036.

14. Engelman D., Yoshizumi J., Hay R. J., et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020;183:808–820. doi: 10.1111/bjd.18943.

15. Rosumeck S., Nast A., Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4(4): CD 012994. doi: 10.1002/14651858.CD012994.

16. Engelman D., Steer A. C. Control Strategies for Scabies. Trop Med Infect Dis. 2018;3(3):98. doi:10.3390/tropicalmed3030098.

17. Lake S. J., Kaldor J. M., Hardy M., et al. Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis. Clin Infect Dis. 2022;75(6):959–967. doi:10.1093/cid/ciac042.

18. El-Moamly A. A. Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021–2030: what we know and what we need to do for global control. Trop Med Health. 2021;49(1):64. doi:10.1186/s41182-021-00348-6.

19. Shen N., Wei W., Chen Y., et al. Vaccination with a cocktail vaccine elicits significant protection against Sarcoptes scabiei in rabbits, whereas the multi-epitope vaccine offers limited protection. Experimental Parasitology. 2023;245:108442. doi:10.1016/j.exppara.2022.108442.

20. Sharaf M. S. Scabies vaccines: where we stand and challenges ahead. Parasitology Research. 2024;123(7):285. doi:10.1007/s00436-024-08298-8.

21. Kim D. H., Kim Y., Yun S. Y., et al. Risk factors for scabies in hospital: a systematic review. BMC Infectious Diseases. 2024;24(1):353. doi: 10.1186/s12879-024-09167-6.


Review

For citations:


Gaydina T.A., Milushkina O.Yu., Skoblina N.A., Tairova R.T. Scabies in a comorbid patient with severe neurological pathology: a clinical case. Medical alphabet. 2024;(31):46-51. (In Russ.) https://doi.org/10.33667/2078-5631-2024-31-46-51

Views: 55


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)